Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency releases new additional guidance for development of antibacterials for public consultation 4 Julij 2012NewsHumanMedicines Janssen-Cilag International NV withdraws its application for an extension of the indication for Velcade (bortezomib) 3 Julij 2012Press release European Medicines Agency finalises update to guideline on renewals 2 Julij 2012NewsHumanRegulatory and procedural guidanceMedicines New pharmacovigilance legislation comes into operation 2 Julij 2012Press releaseCorporate European Medicines Agency welcomes new Head of Safety and Efficacy of Medicines 2 Julij 2012NewsCorporateMedicines European Medicines Agency reminds companies about arrangements before and during Olympic Games 29 Junij 2012NewsCorporateMedicines European Medicines Agency finalises update to diabetes guideline 29 Junij 2012NewsHumanRegulatory and procedural guidanceMedicines Two modules of guideline on good pharmacovigilance practices released for public consultation 27 Junij 2012NewsCorporateRegulatory and procedural guidance Ferrer Internacional, S.A. withdraws its marketing authorisation application for Egrifta (tesamorelin) 26 Junij 2012Press releaseCorporate European Medicines Agency finalises first set of guidelines on good pharmacovigilance practices 25 Junij 2012NewsCorporateRegulatory and procedural guidanceMedicines 1 … 249 250 251 252 253 Page 253 of 384 254 255 256 257 … 384
European Medicines Agency releases new additional guidance for development of antibacterials for public consultation 4 Julij 2012NewsHumanMedicines
Janssen-Cilag International NV withdraws its application for an extension of the indication for Velcade (bortezomib) 3 Julij 2012Press release
European Medicines Agency finalises update to guideline on renewals 2 Julij 2012NewsHumanRegulatory and procedural guidanceMedicines
European Medicines Agency welcomes new Head of Safety and Efficacy of Medicines 2 Julij 2012NewsCorporateMedicines
European Medicines Agency reminds companies about arrangements before and during Olympic Games 29 Junij 2012NewsCorporateMedicines
European Medicines Agency finalises update to diabetes guideline 29 Junij 2012NewsHumanRegulatory and procedural guidanceMedicines
Two modules of guideline on good pharmacovigilance practices released for public consultation 27 Junij 2012NewsCorporateRegulatory and procedural guidance
Ferrer Internacional, S.A. withdraws its marketing authorisation application for Egrifta (tesamorelin) 26 Junij 2012Press releaseCorporate
European Medicines Agency finalises first set of guidelines on good pharmacovigilance practices 25 Junij 2012NewsCorporateRegulatory and procedural guidanceMedicines